Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Truck Series (TRUCK)
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessSolarEdge Technologies Shares Plunge 19 percent Following Q2 Revenue Miss, EPS Beat...

SolarEdge Technologies Shares Plunge 19 percent Following Q2 Revenue Miss, EPS Beat Estimates

Add to Favorite
Added to Favorite


SolarEdge Technologies, Inc. (NASDAQ:SEDG) shares plummeted more than 19% on Wednesday following the company’s reported Q2 results, with revenue coming in at $727.8 million, missing the Street estimate of $730.65 million. Q2 EPS of $0.95 came in better than the Street estimate of $0.88.
The company expects Q3/22 revenue to be in the range of $810-840 million, compared to the Street estimate of $813.27 million.
According to the analysts at Oppenheimer, the company is navigating ongoing supply chain disruptions and FX pressures relatively well. The analysts mentioned they were encouraged to see the company pushing through price increases, expanding its sourcing efforts on key components and evolving its core software capabilities while growing the revenue by over 50%.
The analysts raised their revenue and GAAP EPS estimates to $3.073 billion/$3.12 from $2.987 billion/$3.89. Their 2023 estimates moved to $3.922 billion/$5.53 from $3.819 billion/ $5.60. The analysts raised their price target to $400 from $334, while maintaining their Outperform rating.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Thermo Fisher Scientific Reports Better Than Expected Q1 Results

Thermo Fisher Scientific (NYSE:TMO) announced its first-quarter earnings and...

Humana Drops 5 percent Despite Q1 Beat

Humana (NYSE:HUM) saw its shares drop by around 5%...